Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature

2020 ◽  
Vol 13 (4) ◽  
pp. 313-324
Author(s):  
Dmitry Victorovich Garbuzenko ◽  
Nikolay Olegovich Arefyev
Keyword(s):  
Liver Cirrhosis ◽  
Primary Prevention ◽  
Esophageal Varices ◽  
Review Of The Literature

Principles of primary prophylaxis of bleeding from oesophagealvaricies in patients with liver cirrhosis

2016 ◽  
Vol 94 (7) ◽  
pp. 503-509
Author(s):  
Dmitry V. Garbuzenko
Keyword(s):  
Liver Cirrhosis ◽  
Portal Hypertension ◽  
Primary Prevention ◽  
Esophageal Varices ◽  
Retrieval System ◽  
Primary Prophylaxis ◽  
Inclusion Criteria ◽  
Cochrane Reviews ◽  
Pubmed Database ◽  
Endoscopic Ligation

The principles of primary prevention of bleeding from esophageal varices in patients with liver cirrhosis are discussed with reference to the stage ofportal hypertension. The information was collectedfrom the PubMed database, Google Scholar retrieval system, Cochrane reviews, and lists of references from relevant publications for 1980-2015 using the key words «bleeding from esophageal varices», «prophylaxis», «portal hypertension». Inclusion criteria were confined to primary prophylaxis of bleeding from esophageal varices in patients with liver cirrhosis. The analysis showed that the drugs of choice for primary prophylaxis of bleeding from esophageal varices in patients with liver cirrhosis are non-selective beta-adrenoblockers, but their application is indicated only in case of clinicallyl significant portal hypertension in patients with large and mediumsize esophageal varices. When the use of these drugs is contraindicated, endoscopic ligation of esophageal varices can be recommended.

scholarly journals Primary prevention of bleeding esophageal varices in patients with liver cirrhosis

2020 ◽  
pp. 56-61
Author(s):  
N. N. Smagina
Keyword(s):  
Liver Cirrhosis ◽  
Primary Prevention ◽  
Esophageal Varices ◽  
Beta Blockers ◽  
Control Group ◽  
Endoscopic Screening ◽  
Basic Group ◽  
Drug Of Choice ◽  
Bleeding Esophageal Varices ◽  
Observation Period

Objective: to evaluate the effectiveness of the application of beta-blockers for primary prevention of bleeding esophageal varices in patients with liver cirrhosis. Material and methods. A retrospective study included 46 patients with liver cirrhosis of various etiology having II-III stage esophageal varices. All the patients were divided into two equal groups. The basic group was made up of 23 (50 %) patients who were prescribed beta-blockers at recommended dosages continuously over the observation period from 2009 till 2018 for the purpose of primary prevention of bleeding esophageal varices. The control group included 23 (50 %) patients with liver cirrhosis in whom the primary prevention of the bleedings was not performed. Results. The assessment of the effectiveness of beta-blockers was performed with two indicators: the frequency of bleeding esophageal varices and their mortality. The application of beta-blockers made it possible to reduce the bleeding frequency from 34.8 % to 13 % (р = 0.10) and the mortality from 21.7 % to 0 % (р = 0.02). Conclusion. In order to detect early stages of esophageal varices, endoscopic screening should be performed for all patients with liver cirrhosis. The presence of II-III stage esophageal varices requires primary prevention of the bleedings. The drug-of-choice are non-selective beta-blockers. Timely and adequately prevention reduces the risk of the bleedings and their mortality.

scholarly journals Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis

2014 ◽  
Vol 6 (6) ◽  
pp. 363 ◽  
Author(s):  
Christos Triantos
Keyword(s):  
Liver Cirrhosis ◽  
Primary Prevention ◽  
Esophageal Varices

scholarly journals Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature

2013 ◽  
Vol 33 (10) ◽  
pp. 1457-1469 ◽  
Author(s):  
Kirsten E. Pijls ◽  
Daisy M. A. E. Jonkers ◽  
Elhaseen E. Elamin ◽  
Ad A. M. Masclee ◽  
Ger H. Koek
Keyword(s):  
Liver Cirrhosis ◽  
Barrier Function ◽  
Epithelial Barrier ◽  
Intestinal Epithelial ◽  
Extensive Review ◽  
Review Of The Literature ◽  
Intestinal Epithelial Barrier ◽  
Epithelial Barrier Function

Protein-losing enteropathy as precursor of inflammatory bowel disease: a review of the literature

2021 ◽  
Vol 14 (1) ◽  
pp. e238802
Author(s):  
Fritz Ruprecht Murray ◽  
Bernhard Morell ◽  
Luc Biedermann ◽  
Philipp Schreiner
Keyword(s):  
Inflammatory Bowel Disease ◽  
Liver Cirrhosis ◽  
Female Patient ◽  
Bowel Disease ◽  
Final Diagnosis ◽  
Gastrointestinal Diseases ◽  
Review Of The Literature ◽  
Protein Losing Enteropathy ◽  
Inflammatory Bowel ◽  
Work Up

We report the case of a 63-year-old female patient with liver cirrhosis who presented with symptoms of severe hypoalbuminaemia and diarrhoea. After ruling out other causes of hypoalbuminaemia and confirmation of an elevated faecal α-1 antitrypsin clearance, the diagnosis of protein-losing enteropathy (PLE) could be established. Since PLE is a syndrome caused by various diseases, classified into erosive and non-erosive gastrointestinal diseases or lymphatic obstruction, an extensive work-up was necessary, establishing the final diagnosis of Crohn’s disease.

Multimodal therapy of recurrent and refractory bleeding from esophageal varices – case report and review of the literature

2016 ◽  
Vol 54 (12) ◽  
pp. 1320-1326 ◽  
Author(s):  
M. Buechter ◽  
V. Penndorf ◽  
A. Canbay ◽  
J. Theysohn ◽  
A. Dechêne
Keyword(s):  
Case Report ◽  
Esophageal Varices ◽  
Multimodal Therapy ◽  
Review Of The Literature
Sign in / Sign up

Export Citation Format

Share Document